The role of radiotherapy in ovarian cancer

被引：17

作者：

Durno, Kimberley ^{[1
]}

Powell, Melanie E. ^{[1
]}

机构：

[1] St Bartholomews Hosp, Clin Oncol, London EC1A 7BE, England

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷 / 03期

关键词：

ovarian cancer; radiation; quality of life (pro); palliative care; PALLIATIVE RADIATION-THERAPY; WHOLE ABDOMINAL RADIOTHERAPY; CLEAR-CELL CARCINOMA; PROGNOSTIC-FACTORS; CHEMOTHERAPY; RECURRENT; TRIAL; IRRADIATION; MANAGEMENT; SURVIVAL;

D O I：

10.1136/ijgc-2021-002462

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Epithelial ovarian cancer accounts for around 1.9% of all malignancies and often presents late at an advanced stage. Prognosis is therefore poor. Currently the mainstay of treatment is radical cytoreductive surgery and chemotherapy but, in the past, the standard of care also included adjuvant whole abdominal radiotherapy. This is no longer standard practice, largely due to high toxicity rates and the effectiveness of platinum-based chemotherapy. Presently, a role is emerging for modern radiotherapy techniques in both the salvage and palliative settings. This review aims to examine the historical use of radiotherapy in ovarian cancer before looking forward to its potential future role.

引用

页码：366 / 371

页数：6

共 46 条

[1]

[Anonymous], OV CANC STAT

[2] Adjuvant intensity modulated whole-abdominal radiation therapy for high-risk patients with ovarian cancer FIGO stage III: final results of a prospective phase 2 study [J].

Arians, Nathalie ;

Kieser, Meinhard ;

Benner, Laura ;

Rochet, Nathalie ;

Schroeder, Lars ;

Katayama, Sonja ;

Herfarth, Klaus ;

Schubert, Kai ;

Schneeweiss, Andreas ;

Sohn, Christof ;

Lindel, Katja ;

Debus, Juergen .

RADIATION ONCOLOGY, 2019, 14 (01)

[3] Involved-field radiation therapy for locoregionally recurrent ovarian cancer [J].

Brown, Aaron P. ;

Jhingran, Anuja ;

Klopp, Ann H. ;

Schmeler, Kathleen M. ;

Ramirez, Pedro T. ;

Eifel, Patricia J. .

GYNECOLOGIC ONCOLOGY, 2013, 130 (02) :300-305

[4] CHEMOTHERAPY VERSUS RADIOTHERAPY IN THE MANAGEMENT OF OVARIAN-CANCER PATIENTS WITH PATHOLOGICAL COMPLETE RESPONSE OR MINIMAL RESIDUAL DISEASE AT 2ND LOOK [J].

BRUZZONE, M ;

REPETTO, L ;

CHIARA, S ;

CAMPORA, E ;

CONTE, PF ;

ORSATTI, M ;

VITALE, V ;

RUBAGOTTI, A ;

ROSSO, R .

GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :392-395

[5] Prognostic factors for high-risk early-stage epithelial ovarian cancer - A Gynecologic oncology group study [J].

Chan, John K. ;

Tian, Chunqiao ;

Monk, Bradley J. ;

Herzog, Thomas ;

Kapp, Daniel S. ;

Bell, Jeffrey ;

Young, Robert C. .

CANCER, 2008, 112 (10) :2202-2210

[6] HIGH-RISK EARLY-STAGE OVARIAN-CANCER - RANDOMIZED CLINICAL-TRIAL COMPARING CISPLATIN PLUS CYCLOPHOSPHAMIDE VERSUS WHOLE ABDOMINAL RADIOTHERAPY [J].

CHIARA, S ;

CONTE, P ;

FRANZONE, P ;

ORSATTI, M ;

BRUZZONE, M ;

RUBAGOTTI, A ;

ODICINO, F ;

RUGIATI, S ;

CARNINO, F ;

ROSSO, R ;

RAGNI, N .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (01) :72-76

[7]

Choi N, 2017, RADIAT ONCOL J, V35, P144, DOI 10.3857/roj.2017.00213

[8] Clear cell carcinoma of the ovary: A review of the literature [J].

del Carmen, Marcela G. ;

Birrer, Michael ;

Schorge, John O. .

GYNECOLOGIC ONCOLOGY, 2012, 126 (03) :481-490

[9]

DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263

[10] EPITHELIAL OVARIAN-CANCER - THE ROLE OF RADIOTHERAPY [J].

DEMBO, AJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05) :835-845

← 1 2 3 4 5 →